A new study is turning conventional wisdom on its head by revealing that common over-the-counter (OTC) pain medications like ibuprofen and acetaminophen may significantly accelerate recovery from concussions.
For years, treatment for concussions—mild traumatic brain injuries—has been mostly limited to rest, time, and monitoring. But now, scientists from the University of Washington in Seattle are suggesting a simple, accessible way to potentially reduce recovery time: taking everyday pain relievers.
“These results are exciting as there are limited treatment options for concussion, and over-the-counter pain relievers are readily available and inexpensive,” said study author Dr. Kyle Arnold.
Concussion Recovery Enhanced by OTC Medications
The study focused on a specific group of individuals who are statistically more prone to concussions—athletes and military cadets. These are individuals who regularly participate in physically intense activities and are at higher risk for head injuries due to collisions, falls, and high-impact motion.
Out of 1,660 participants diagnosed with concussions, nearly half—813 people—used over-the-counter pain medications after their injury. These medications included widely known drugs such as ibuprofen, acetaminophen, and other non-steroidal anti-inflammatory drugs (NSAIDs). Meanwhile, 848 individuals did not take any form of OTC pain relief during their recovery.
Researchers tracked how long it took for participants to recover enough to return to their usual activities without any restrictions. Recovery was analyzed at two milestones: when 50% of the group had fully recovered, and later when 90% had recovered. These benchmarks allowed scientists to measure average recovery timelines and determine whether medication had a measurable impact.
Painkillers Shave Days Off Recovery Time
The difference in recovery speed between those who took painkillers and those who didn’t was notable. The individuals who took OTC medications were 20% more likely to return to unrestricted activity sooner. In concrete terms, this meant those at the 50% recovery mark returned to full activity roughly two days earlier than non-medicated individuals. By the time 90% of the group had recovered, that gap had stretched to seven days.
In addition to getting back to regular activity more quickly, those taking painkillers also reported faster relief from symptoms. At 50% recovery, they achieved zero symptoms a full day earlier, and at 90% recovery, that advantage grew to three days.
But it wasn’t just about how quickly symptoms disappeared. Painkiller users also scored better in assessments evaluating the severity of concussion-related symptoms—such as nausea, dizziness, and fatigue—and specifically, the intensity of headaches, which are among the most common aftereffects of a concussion.
Timing Matters: Sooner Is Better
Perhaps one of the most compelling aspects of the research was how much timing influenced recovery outcomes. Those who began taking pain relievers on the first day of their injury saw their symptoms resolve and returned to work or activity nearly eight days faster than those who waited five or more days to begin using them.
This early intervention benefit held true regardless of which type of OTC pain reliever was used. The researchers found no major differences in performance between acetaminophen, ibuprofen, or other NSAIDs.
“These preliminary results may help inform potential treatment options for people recovering from concussions,” Dr. Arnold added.
However, he also emphasized the need for further investigation, noting that “additional studies were needed to provide more definitive recommendations.”
A Step Forward in Concussion Care
These findings, scheduled to be presented at the American Academy of Neurology’s annual meeting in San Diego from April 5–9, could potentially reshape how concussions are managed both at home and in clinical settings.
Until now, recovery protocols have largely centered around rest and symptom monitoring, with little active intervention unless symptoms worsened. This study opens the door to a simple, affordable, and accessible supplement to standard concussion care.
If future research supports these results, it could lead to new recommendations in sports medicine, military health protocols, and everyday first-aid practices. Given the widespread availability and affordability of OTC painkillers, this could be an especially important breakthrough for low-resource environments where advanced neurological care isn’t easily accessible.
For now, though, experts urge caution. While the data is promising, it is still early, and individuals recovering from a concussion should always consult with a medical professional before beginning any treatment—even with medications that seem harmless.
Nonetheless, the research represents an exciting potential shift in how we approach concussion recovery. With something as simple as a bottle of ibuprofen, recovery could not only become faster but also less painful—both physically and emotionally—for thousands of people each year.
Recommended For You
